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Abstract
Background
Smoking is the main risk factor for most of the leading causes of death. Cessation is the
single most important step that smokers can take to improve their health. With the aim of
informing policy makers about decisions on future tobacco control strategies, we estimated
time and age trends in smoking cessation in Europe between 1980 and 2010.
Methods
Data on the smoking history of 50,228 lifetime smokers from 17 European countries were
obtained from six large population-based studies included in the Ageing Lungs in European
Cohorts (ALEC) consortium. Smoking cessation rates were assessed retrospectively, and
age trends were estimated for three decades (1980–1989, 1990–1999, 2000–2010). The
analyses were stratified by sex and region (North, East, South, West Europe).
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Results
Overall, 21,735 subjects (43.3%) quit smoking over a total time-at-risk of 803,031 years.
Cessation rates increased between 1980 and 2010 in young adults (16–40 years), espe-
cially females, from all the regions, and in older adults (41–60 years) from North Europe,
while they were stable in older adults from East, South and West Europe. In the 2000s,
the cessation rates for men and women combined were highest in North Europe (49.9 per
1,000/year) compared to the other regions (range: 26.5–32.7 per 1,000/year). A sharp peak
in rates was observed for women around the age of 30, possibly as a consequence of preg-
nancy-related smoking cessation. In most regions, subjects who started smoking before the
age of 16 were less likely to quit than those who started later.
Conclusions
Our findings suggest an increasing awareness on the detrimental effects of smoking across
Europe. However, East, South and West European countries are lagging behind North
Europe, suggesting the need to intensify tobacco control strategies in these regions. Addi-
tional efforts should be made to keep young adolescents away from taking up smoking, as
early initiation could make quitting more challenging during later life.
Introduction
Smoking is the main risk factor for most of the leading causes of death.[1] Every year about 1.6
million Europeans die because of smoking, making Europe the region with the greatest pro-
portion of deaths (16%) attributable to tobacco worldwide.[2] Tobacco smoking is also a finan-
cial burden on European healthcare systems and economies.[3]
In developed countries, smoking has been associated with a loss of at least a decade of life.
[4] However cessation, especially before the age of 40 years, can dramatically reduce the risk of
death and significantly improve quality of life.[4] It is therefore critical to encourage all current
smokers to quit in order to reduce the burden of smoking-related diseases and mortality.[2,3]
European countries have introduced various tobacco control policies (e.g. increased taxa-
tion of tobacco products, no-smoking areas, advertising bans, graphic pack warnings, and
smoking cessation programs) over recent decades. Despite a general decrease in tobacco con-
sumption and the prevalence of smoking, still more than one in four of the European popula-
tion over the age of 14 years is an active smoker.[5]
Variations in smoking prevalence are determined by variations in the rates of initiation,
cessation and relapse. For this reason, monitoring trends in these rates is fundamental for eval-
uating current tobacco control policies and for planning future strategies that can effectively
tackle the tobacco epidemic.[2] Nonetheless, there is an extreme paucity of studies on smoking
cessation in the general European population.
With the aim of better informing public health policy makers about decisions on future
tobacco control strategies, we estimated age trends in smoking cessation in Europe for the
three decades between 1980 and 2010. The present analysis compliments our previous report
on smoking initiation in Europe [6].
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Methods
Study design and population
We analysed data obtained from six multicentre studies on random samples of the general
adult population carried out in Europe between 1991 and 2013, which became part of the Age-
ing Lungs in European Cohorts (ALEC) consortium (www.alecstudy.org).
The Global Allergy and Asthma Network of Excellence (GA2LEN, www.ga2len.net) is an
international cross-sectional study that was carried out on people aged 15–75 years between
2007 and 2009.[7] The Italian Study on Asthma in Young Adults (ISAYA) is a postal cohort
study on subjects aged 20–44 at enrolment in 1998–2000, who were followed up in 2008–2009.
[8] The Genes Environmental Interaction in Respiratory Diseases (GEIRD, www.geird.org) is
a cross-sectional study carried out in Italy between 2005 and 2010.[9]
The European Community Respiratory Health Survey (ECRHS, www.ecrhs.org) is an inter-
national cohort study performed on subjects aged 20–44 years at enrolment in 1991–1994.[10]
In ECRHS I, random samples of subjects participating in a postal screening (stage 1) took part
in a clinical interview (stage 2), where they reported information on smoking habits for the
first time. The cohort of participants in stage 2 (labelled “ECRHS clinical” throughout the
manuscript) was reassessed at two independent examinations during 1999–2002 in ECRHS II,
[11] and during 2010–2013 in ECRHS III.[12] The Italian arm of the ECRHS (ECRHS-Italy) is
the postal follow-up of the Italian participants in ECRHS stage-1, who were surveyed in 1998–
2001 and 2008–2009.[13,14] The Respiratory Health in Northern Europe study (RHINE,
www.rhine.nu) is a postal follow-up of the ECRHS I stage-1 participants from Scandinavian
and Estonian centres, carried out in 2010–2012 (RHINE II).[15] A flow-chart describing how
the three cohorts stem from the ECRHS study can be found at https://doi.org/10.1371/journal.
pone.0201881.s009.
The analyses were performed on data pooled from the six studies. Subjects who had partici-
pated in more than one study or occasion were only considered once. The distribution of sub-
jects by sample (i.e. the original centre and study where the subjects were surveyed) is shown
in S1 Table. Overall, 73 samples from 53 centres in 17 countries were included, while four sam-
ples with a low participation rate (below 25%) were discarded. The samples were grouped
into four regions, according to the United Nations geoscheme and tobacco epidemiology:[16]
South Europe (Italy, Portugal, Spain), West Europe (Belgium, France, Germany, the Nether-
lands, Switzerland), North Europe (Denmark, Finland, Iceland, Norway, Sweden, United
Kingdom), and East Europe (Estonia, Macedonia, Poland).
Data on smoking
The smoking history of each subject was reconstructed retrospectively using data from postal
questionnaires for all studies, in addition to data from clinical interviews for ECRHS.[Table 1]
In all studies, with the exception of RHINE (where the subjects qualified themselves as “smok-
ers” or “ex-smokers”), smoking was defined as active smoking for as long as a year (regular
smoking). Life-long never smokers were excluded from the analyses. A smoker who reported
not to have smoked at all in the last month was considered an ex-smoker. Age at initiation
was based on the question “How old were you when you started smoking?” for all the studies.
Questions on age at cessation referred to the time of stopping or the last time smoking, with a
slightly different wording across studies.[Table 1] For subjects with follow-up data (ECRHS
clinical, ECRHS-Italy, ISAYA), the first information available was chosen for defining age at
initiation, while age at cessation was based on the last information available.
Trends in smoking cessation in Europe
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Statistical analysis
Rates of smoking cessation (per 1,000/year) were calculated as the ratio between the number of
incident quitters and the total time at risk, which was defined as years from initiation to cessa-
tion for quitters, or from initiation to the last survey available for active smokers. To avoid
data sparseness, time at risk was left-censored at age 16 years and at 1980, and right-censored
at age 60 years and at 2010.
All the analyses were stratified by sex, region, and period (1980–1989, 1990–1999, 2000–
2010). Crude rates were calculated for two age groups: 16–40 and 41–60 years. In the main
analyses, age-specific trends of smoking cessation rates (with 95% confidence intervals) were
estimated using two-level mixed-effects models (with subjects nested into samples), with a
negative binomial outcome distribution, a logarithmic link function and an offset for log(per-
son-years). Period was included as a linear term to adjust for possible time trends of cessation
rates within each decade. Age was modelled using natural smoothed polynomial lines (splines),
and the number of knots (four and five for males and females, respectively) was chosen based
on model fit using the Bayesian information criterion.
As the risk of relapse is high in the first year after quitting, while it drastically drops after-
wards,[17] we performed a sensitivity analysis defining smoking cessation as having quitted
smoking for at least two years (with person-years re-calculated accordingly), in order to
exclude subjects who might have quit smoking just for a brief time before the survey.
Finally, to evaluate whether subjects who started smoking in early adolescence had a differ-
ent attitude toward smoking cessation compared to those who started later, the main models
were fitted including a binary indicator for age at initiation (10–15 vs.�16 years) as a predic-
tor variable. In this analysis, since we found no evidence of interaction between age at initia-
tion and period, the three decades were combined to increase the statistical power.
The statistical analyses were performed using STATA 14.2 (StataCorp, College Station,
TX).
Ethics approval and consent to participate
Ethical approval was not requested for this secondary analysis of pooled data from previous
studies. In each of the original studies, ethical approval was obtained for each centre from the
appropriate ethics committee. All procedures have conformed to the principles embodied in
Table 1. Questionnaire items on smoking.
Study Smoking status Age at initiation Current smoking Age at cessation
GA2LEN Have you ever smoked for as long as a year? [’YES’ means at
least one cigarette per day or one cigar per week for one year]
How old were you
when you started
smoking?
Have you smoked at
all in the last
month?
How old were you when
you stopped smoking?
RHINE Are you a smoker? (this applies even if you only smoke the odd
cigarette/ cigar or pipe every week)
Are you an ex-
smoker?





Have you ever smoked for as long as a year? [’YES’ means at
least one cigarette per day or one cigar per week for one year]
Do you now smoke,
as of one month
ago?




Have you ever smoked for as long as a year? [’YES’ means at
least 20 packs of cigarettes or 12 oz (360 grams) of tobacco in a
lifetime, or at least one cigarette per day or one cigar per week for
one year]
Do you now smoke,
as of one month
ago?
How old were you when




Have you ever smoked for as long as a year? Have you smoked
in the last month?
How old were you when
you last smoked?
�only the answers from subjects who quit smoking were considered.
https://doi.org/10.1371/journal.pone.0211976.t001
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the Declaration of Helsinki. Written informed consent was obtained from participants in
the clinical examinations (ECRHS clinical). In ECRHS-Italy, RHINE, GA2LEN, ISAYA and
GEIRD, only data from postal questionnaires were used, which were voluntarily sent back giv-
ing consent to use the anonymized data.
Results
A total of 50,228 ever smokers with complete information on sex, year of birth, age at smoking
initiation and, if applicable, age at cessation were included in the analysis.[S1 Fig and S1 Table]
The distribution of the participants by study and year is shown in S2 Fig. GA2LEN was the
study that contributed the highest number of subjects (n = 22,100). Overall, 14.0% (n = 7,058)
of the subjects had follow-up data.
Females represented about half of the sample, and the median age at the last interview
ranged from 38 to 50 years for subjects from South and North Europe, respectively. Overall,
43.3% (n = 21,735) of the subjects quit smoking over a total time-at-risk of 803,031 person-
years. The proportion of quitters was highest in North Europe (56.0%) compared to other
European regions (range: 34.1% to 37.9%).[Table 2]
Trends in smoking cessation
In the 2000s, the crude cessation rates for males and females combined were highest in North
Europe (49.9 per 1,000/year) compared to the other regions (range: 26.5–32.7 per 1,000/year).
For males and females aged less than 40 years, cessation rates were considerably higher in the
2000s compared to the preceding two decades in all the four regions. This was especially evi-
dent in North Europe, where the cessation rates doubled, from 24 per 1,000/year in the 1980s
to 53 per 1,000/year in the 2000s. On the other hand, cessation rates after the age of 40 were
similar across successive periods, with the exception of North Europe where the rates doubled,
from 23 per 1,000/year in the 1980s to 47 per 1,000/year in the 2000s.
Consistent results were found when looking separately at males and females.[Table 3]
Table 2. Demographic and smoking history data of the subjects included in the analyses, by region.
North Europe East Europe South Europe West Europe Overall
Countries, n 6 3 3 5 17
Centres, n 15 5 19 14 53
Subjects included, n 18,255 5,013 19,179 7,781 50,228
Females, n (%) 9,927 (54.4) 2,399 (47.9) 8,716 (45.5) 3,882 (49.9) 24,924 (49.6)
Birth year � 1958 (1940–1983) 1961 (1940–1986) 1964 (1948–1980) 1961 (1943–1986) 1962 (1942–1984)
Year of last interview � 2008 (2002–2011) 2008 (2007–2012) 2001 (1998–2010) 2008 (1991–2012) 2008 (1998–2011)
Age at last interview (years) � 50 (24–68) 47 (22–67) 38 (23–60) 43 (22–66) 43 (23–66)
Study, n (%)
ECRHS clinical 2,389 (13.1) 214 (4.3) 1,764 (9.2) 3,263 (41.9) 7,630 (15.2)
ECRHS-Italy - - 1,808 (9.4) - 1,808 (3.6)
RHINE 3,665 (20.1) 364 (7.3) - - 4,029 (8.0)
ISAYA - - 8,788 (45.8) - 8,788 (17.5)
GEIRD - - 5,873 (30.6) - 5,873 (11.7)
GA2LEN 12,201 (66.8) 4,435 (88.5) 946 (4.9) 4,518 (58.1) 22,100 (44.0)
Quitters, n (%) 10,224 (56.0) 1,707 (34.1) 6,854 (35.7) 2,950 (37.9) 21,735 (43.3)
Total person-years 309,077 89,194 287,637 117,123 803,031
� median (5th-95th percentile)
https://doi.org/10.1371/journal.pone.0211976.t002
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Fig 1 shows the smoothed age-trends in smoking cessation by sex, region, and period.[Fig
1] We observed a peak in smoking cessation around the age of 30, which was particularly evi-
dent in the 2000s. This peak was quite blunted in men, while it was very sharp in women and
corresponded to an age of 31 years in South Europe, 28 years in West and North Europe, and
26 years in East Europe. From the age of 40 onwards, the smoking cessation rates increased
gradually in males and females from all regions.
Smoking cessation according to age at initiation
Except for males from South Europe, where the incidence rate ratio (IRR) for later age at initi-
ation was below 1 and not statistically significant (IRR 0.97, 95%CI: 0.90–1.04), the likelihood
of quitting was higher for both men and women who started smoking at 16 years or later com-
pared to those who started earlier, with IRRs ranging from 1.05 (95%CI: 0.88–1.24) in East
European males to 1.14 (95%CI: 1.07–1.21) in North European males.[Fig 2]
Table 3. Crude rates of smoking cessation (per 1,000/year), number of quitters and person-years at risk in males and females by region, age group and period.
Region Age group Males Females
1980–1989 1990–1999 2000–2010 1980–1989 1990–1999 2000–2010
North Europe 16–40 years rates† 24.7 31.2 49.8 23.0 33.4 56.1
quitters 1,150 950 714 1,252 1,321 1,111
py 46,594 30,445 14,336 54,329 39,553 19,808
41–60 years rates† 25.0 31.1 48.6 20.3 28.7 45.6
quitters 227 667 979 171 623 1,059
py 9,066 21,422 20,131 8,444 21,733 23,216
East Europe 16–40 years rates† 11.8 16.8 23.5 9.4 15.1 30.2
quitters 151 190 172 105 153 200
py 12,845 11,312 7,320 11,210 10,146 6,619
41–60 years rates† 22.4 28.9 28.5 18.0 19.5 24.3
cases 60 175 190 31 108 172
py 2,682 6,051 6,665 1,722 5,541 7,081
South Europe 16–40 years rates† 17.8 22.4 33.3 20.4 24.6 36.9
quitters 961 1,376 649 930 1,256 610
py 54,084 61,528 19,513 45,515 51,002 16,547
41–60 years rates† 30.3 30.1 33.8 15.1 21.2 22.2
quitters 94 299 317 20 149 193
py 3,098 9,946 9,373 1,323 7,015 8,693
West Europe 16–40 years rates† 20.8 24.1 33.3 22.3 22.8 32.7
quitters 459 304 253 461 295 300
py 22,118 12,608 7,609 20,678 12,951 9,162
41–60 years rates† 32.6 28.0 32.4 22.9 24.9 23.1
cases 93 193 240 43 140 169
py 2,856 6,891 7,416 1,878 5,633 7,323
Overall 16–40 years rates† 20.1 24.3 36.7 20.9 26.6 42.6
quitters 2,721 2,820 1,788 2,748 3,025 2,221
py 135,641 115,893 48,778 131,732 113,652 52,136
41–60 years rates† 26.8 30.1 39.6 19.8 25.5 34.4
cases 474 1,334 1,726 265 1,020 1,593
py 17,702 44,310 43,585 13,367 39,922 46,313
†: quitters per 1,000/year. py: person-years.
https://doi.org/10.1371/journal.pone.0211976.t003
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Fig 1. Estimated trends in smoking cessation rates (per 1,000/year) with 95% confidence intervals in females and
males, by region. Trends were stratified by period: black lines refer to 1980–1989; red lines refer to 1990–1999, and
green lines refer to 2000–2010.
https://doi.org/10.1371/journal.pone.0211976.g001
Trends in smoking cessation in Europe
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Probability of smoking relapse after quitting
Among ex-smokers, the median duration of abstinence from smoking reported at the time of
the interview was 10 years (25th-75th percentiles: 4–18), and over 90% had quit for at least 2
years.
The risk of relapse was estimated using subjects with follow-up data.[S2 Table] Overall,
12.2% of those who were ex-smokers at the baseline examination reported to be active smokers
at the last follow-up (average follow-up time: 16.5 years). The proportion of subjects relapsing
was significantly greater in those who had quit smoking for less than 2 years at baseline (nearly
30%) compared to those who had quit smoking for at least 2 years (less than 10%) (p<0.001).
Discussion
We retrospectively investigated trends in smoking cessation across three decades from 1980 to
2010, using representative samples of the general population from 17 European countries.
The main results of our analyses are the following:
• rates of smoking cessation were higher in North Europe than in West, South, and East
Europe;
Fig 2. Age and period-adjusted incidence rate ratios of smoking cessation, with 95% confidence intervals, for subjects who started smoking at 16
years or later compared to those who started earlier, by sex and European region.
https://doi.org/10.1371/journal.pone.0211976.g002
Trends in smoking cessation in Europe
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• smoking cessation has been steadily increasing between the 1980s and the 2000s among
smokers aged under 40 years across Europe; among older people, this was observed only for
North Europe;
• smoking cessation rates peak around the age of 30 in women;
• quitting was less likely for subjects who took up smoking before the age of 16 compared to
people starting later.
Time trends in smoking cessation across European regions
We showed that the rate of smoking cessation was 49.9 per 1,000/year in North Europe
(United Kingdom and Scandinavian countries) in 2000–2010, which is about 60% higher
compared to the other regions. Cessation rates for North Europe confirm the rates recently
reported from RHINE, which is one of the cohorts included in this study,[18] while we are not
aware of studies reporting cessation rates for the other regions.
We found that the rates of cessation have been increasing in North Europe since the end of
the last century, while in the rest of Europe they have started to grow only after the year 2000.
Moreover, in North Europe, the increasing trends in smoking cessation involved both young
(16–40 years) and older (41–60 years) adults, while in the rest of Europe they were restricted to
young adults. These results compliment a previous report on smoking initiation using data
from the same studies, where we observed lower rates of uptake of regular smoking in North
Europe compared to the other regions.[6] Overall, the geographical pattern in smoking cessa-
tion described in our study is consistent with the pattern in smoking prevalence across Euro-
pean countries reported by others [4, 19,20]. These data testify to the better implementation
of effective tobacco control policies in countries of North Europe.[21] Of note, the higher
attained education and wealth per-capita in North Europe might also have contributed to
boost tobacco control strategies, as preventative measures are more effective among higher
socioeconomic groups.[22]
Age trends in smoking cessation in males and females
We found that the rates of smoking cessation were broadly similar in men and women within
the same European region in the 2000s, but there was a remarkable gender difference in age
trends. In fact, while the cessation rates were similar in young and older men, women aged
less than 40 years had significantly higher rates than older women. These findings are in agree-
ment with another study on population data from USA, Canada, and UK, which showed that
women were more likely to have given up smoking than men before their fifties, and vice-versa
after the age of 50.[23]
We also found a sharp peak of cessation around the age of 30 in women from all regions,
which was especially evident in the 2000s. The peak slightly shifted at different ages according
to the region, matching well with mothers’ mean age at first child that ranges from 26–27 years
in East Europe to 30–31 years in South Europe.[24] This suggests that pregnancy is the pri-
mary reason for quitting in women. Previous reports showed that about three out of 4 women
stop smoking during pregnancy,[25] and cessation is more frequent when expecting the first
child.[26]
The more evident peaks of cessation in the 2000s most likely reflect an increasing awareness
of the negative health impact associated with smoking during pregnancy for both the mother
and the foetus,[27] and growing perception of the need to protect children from second-hand
smoke exposure. Social stigma towards expecting mothers who smoke can also encourage
Trends in smoking cessation in Europe
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cessation.[28] The blunted peak observed around the age of 30 among males may also be deter-
mined by parenthood, as fathers try to abstain from smoking to be supportive to their partners’
attempts to quit during pregnancy,[29,30] and to avoid their children being exposed to sec-
ond-hand smoke.[31]
After the age of 40, rates of cessation gradually increased in both men and women, maybe
indicating a growing concern about smoking-related illnesses with ageing.[32]
Age at initiation affects the likelihood to quit
Although overall rates of smoking initiation have decreased considerably in Europe during
recent decades, initiation in young adolescents (11–15 years) has alarmingly increased.[6]
Early initiation is associated with increased risk of smoking-related mortality and morbidity.
[33] Males starting smoking before age 15 may have children with an increased risk of respira-
tory diseases, possibly through epigenetic changes in sperm precursor cells.[34] We found that
early age at initiation is associated with lower rates of cessation, in agreement with other stud-
ies from North America.[35,36] Early initiation has been associated with greater risk of relapse
after cessation.[37] Younger adolescents develop nicotine addiction after a shorter duration of
smoking and a lower number of cigarettes compared to those who take up smoking later.[38]
All these findings suggest that tobacco control strategies targeting the youngest should be
implemented with the aim of discouraging early smoking, or at least delaying initiation.
Strengths and limitations
The main strengths of our study are the inclusion of large samples of subjects from 17 Euro-
pean countries and a long observation period, allowing the comparison of cessation rates
across different regions and their trends during three decades.
A drawback is that this is an observational retrospective study that relies on self-reported
information on smoking history, and smoking status was not verified with biochemical meth-
ods. However, the agreement between self-reported smoking and cotinine levels is generally
good in population studies.[39]
Another limitation is the potential telescoping bias, as individuals might be inaccurate in
recalling the timing of past events. However, we found that age at smoking initiation was con-
sistently reported up to two decades apart (see https://doi.org/10.1371/journal.pone.0201881.
s001 and S3 Table).
The risk of relapse is the main issue when studying smoking cessation. About half of smok-
ers attempts to quit every year, but less than 10% achieves abstinence for a period of at least 6
months.[40] The first year after a quit attempt is the period at highest risk for relapse.[17] In
our study, age at cessation reported in a sub-sample of ex-smokers with follow-up data
(ECRHS clinical) increased by two years on average after 20 years, probably indicating smok-
ing relapses. However, we derived age at cessation from the last time point available, and over
90% of quitters had abstained from smoking for at least two years before the interview, sug-
gesting that our findings mainly reflect smoking cessation over an extended period among
subjects at a low risk of relapse. Moreover, the main results were confirmed in a sensitivity
analysis using a more conservative definition of smoking cessation (having quitted for at least
two years; S3 Fig).
Conclusions
Our findings indicate that smoking cessation rates are increasing throughout Europe, espe-
cially for women around the age of 30, suggesting that there is a mounting awareness of the
detrimental effects of smoking exposure. Scandinavian countries and the UK have greater
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cessation rates than the rest of Europe, where the implementation of tobacco control strategies
should be intensified. Additional efforts should be made to prevent adolescents taking up
smoking, as early initiation could make quitting smoking more challenging during later life.
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